We are live on
!
Find out more
CCM
Camber Capital Management Portfolio holdings
AUM
$718M
1-Year Est. Return
8.19%
This Fund
S&P 500
This Quarter
Est. Return
-10.34%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$718M
AUM Growth
-$885M
(-55%)
Cap. Flow
-$771M
Cap. Flow
% of AUM
-107.36%
Top 10 Holdings %
Top 10 Hldgs %
78.87%
Holding
35
New
4
Increased
1
Reduced
16
Closed
9
Top Buys
| 1 |
Icon
ICLR
|
+$42.6M |
| 2 |
Merck
MRK
|
+$39.7M |
| 3 |
UnitedHealth
UNH
|
+$38.2M |
| 4 |
APLS
Apellis Pharmaceuticals
APLS
|
+$15.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$5.89M |
Top Sells
| 1 |
Zimmer Biomet
ZBH
|
+$121M |
| 2 |
Humana
HUM
|
+$106M |
| 3 |
Baxter International
BAX
|
+$87.9M |
| 4 |
CVS Health
CVS
|
+$78.7M |
| 5 |
PTC Therapeutics
PTCT
|
+$76.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Zimmer Biomet
ZBH
$17.5B
| $91.2M | 12.71% |
1,000,000
-1,250,000
| -56% | -$121M |
|
|
2
Baxter International
BAX
$11.5B
| $86.3M | 12.02% |
2,850,000
-2,900,000
| -50% | -$87.9M |
|
|
3
Humana
HUM
$49.2B
| $73.3M | 10.22% |
300,000
-425,000
| -59% | -$106M |
|
|
4
CVS Health
CVS
$136B
| $72.4M | 10.09% |
1,050,000
-1,200,000
| -53% | -$78.7M |
|
5
Globus Medical
GMED
$10.6B
| $47.2M | 6.58% |
800,000
-450,000
| -36% | -$29.1M |
|
|
6
Icon
ICLR
$13B
| $43.6M | 6.08% |
+300,000
| New | +$42.6M |
|
7
Ascendis Pharma A/S
ASND
$17.5B
| $43.1M | 6.01% |
250,000
-100,000
| -29% | -$16.3M |
|
|
8
Merck
MRK
$305B
| $39.6M | 5.51% |
+500,000
| New | +$39.7M |
|
9
Pfizer
PFE
$141B
| $36.4M | 5.06% |
1,500,000
-1,000,000
| -40% | -$23.3M |
|
|
10
BioMarin Pharmaceuticals
BMRN
$11.3B
| $33M | 4.59% |
600,000
+100,000
| +20% | +$5.89M |
|
|
11
UnitedHealth
UNH
$382B
| $31.2M | 4.35% |
+100,000
| New | +$38.2M |
|
12
Viatris
VTRS
$19.2B
| $24.6M | 3.42% |
2,750,000
-4,750,000
| -63% | -$40.2M |
|
13
Brookdale Senior Living
BKD
$3.48B
| $15M | 2.08% |
2,150,000
-4,100,000
| -66% | -$26.7M |
|
|
ZIMV
14
DELISTED
ZimVie
ZIMV
| $15M | 2.08% |
1,600,000
-285,000
| -15% | -$2.6M |
|
|
APLS
15
DELISTED
Apellis Pharmaceuticals
APLS
| $14.7M | 2.05% |
+850,000
| New | +$15.7M |
|
16
Myriad Genetics
MYGN
$592M
| $10.6M | 1.48% |
2,000,000
-350,000
| -15% | -$2.07M |
|
17
Evolent Health
EVH
$651M
| $9.57M | 1.33% |
850,000
-2,150,000
| -72% | -$19.7M |
|
|
CON
18
Concentra Group Holdings
CON
$3.95B
| $8.23M | 1.15% |
400,000
-1,200,000
| -75% | -$25.6M |
|
19
Inogen
INGN
$173M
| $6.85M | 0.95% |
975,000
| – | – |
|
20
Denali Therapeutics
DNLI
$3.64B
| $5.6M | 0.78% |
400,000
-850,000
| -68% | -$12M |
|
21
Theravance Biopharma
TBPH
$879M
| $4.96M | 0.69% |
450,000
-550,000
| -55% | -$5.35M |
|
22
AnaptysBio
ANAB
$1.68B
| $2.77M | 0.39% |
125,000
-625,000
| -83% | -$13.1M |
|
23
OraSure Technologies
OSUR
$291M
| $2.7M | 0.38% |
900,000
| – | – |
|
24
Cigna
CI
$79.5B
| – | – |
-200,000
| Closed | -$65.8M |
|
25
Genmab
GMAB
$17.9B
| – | – |
-50,000
| Closed | -$979K |
|
Similar funds
CCP
ECM
BC
BWA
SC
TSWM
WCWM
SXL